This is a limited company view. Sign up for a Free Trial to see everything.

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

B2B
Biotechnology
Healthcare
Medical Diagnostics
Pharmaceuticals

Overview

Location

Basel

Founded

Employees

0

Stage

Acquired

Total funding

$21M

Last funding

7 years ago

Acquisitions

0

Growth score

-36

Mindshare score

-36

Scoring

Deals

Employee Growth

Use Okairos's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Okairos's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial